gip vs glp-1 The activity of and for Type 2 Diabetes and Obesity GLP-1/GIP Receptor Agonists and Diabetic
Description
launch is expected early January 2026
SGLT2 inhibitors are actually protective for kidneys, slowing disease progression
Aspiration can lead to serious complications or death
Within the GLP-1 analog, Ala8 is replaced by Gly to resist DPP-4 degradation, and Gly36 is substituted for Arg to avoid a potential T-cell epitope interaction [86]
